The pathology of human and murine pulmonary infection with Cryptococcus neoformans var. gattii

Pathology

Volumn 33, Issue 4, 2001, Pages 475-478

  Torda, Adrienne ^a,b   Kumar, Rakesh K ^a   Jones, Philip D ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Cryptococcus neoformans; Granulomatous inflammation; Immunohistochemistry; Mouse model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CASE REPORT; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FEMALE; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG INFECTION; MOUSE; NONHUMAN; PATHOGENESIS; T LYMPHOCYTE;

EID: 0035677942     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020120083197     Document Type: Article

References (21)

1. Cryptococcal disease of the CNS in immunocompetent hosts - Influence of cryptococcal variety on clinical manifestations and outcome
2. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans
3. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand
4. Cryptococcosis: Current status
5. Natural habitat of Cryptococcus neoformans var. gattii
6. Antibody immunity and invasive fungal infections
7. Cryptococcosis histologically resembling histoplasmosis
8. Pulmonary cryptococcosis
9. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4 + and CD8 + T cells
10. Role of the capsule in phagocytosis of Cryptococcus neoformans
11. Cryptococcus neoformans II. Phagocytosis by human leukocytes
12. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages
13. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses
14. Tumor necrosis factor-inducing activities of Cryptococcus neoformans components
15. Macrophage-Cryptococcus interactions
16. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1-beta secretion from human monocytes
17. Inhibition of phagocytosis by cryptococcal polysaccharide: Dissociation of the attachment and ingestion phases of phagocytosis
18. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast
19. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans
20. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans - Response
21. Cryptococcus neoformans var. gattii meningitis in an Australian patient with AIDS